Skip to content

Opko Health OPK EBITDA margin

EBITDA margin at other companies

Quest Diagnostics logo
Quest DiagnosticsDGX
19.4%+0.6pp
HRO
HarrowHROW
8%+5.0pp
Precigen logo
PrecigenPGEN
-2,807.8%
Immunome logo
ImmunomeIMNM
-5,886.7%-11,897pp
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
-78.7%-2.1pp
Abbott logo
AbbottABT
24.1%-0.2pp

Other financials

Income statement

See full
Revenue$124.2M-17.2%
Gross profit$45.8M+7.4%
Operating income-$51.0M+24.0%
Net income-$54.8M+18.9%
EPS (diluted)-$0.07+30.0%

Balance sheet

See full
Cash & equivalents$40.6M-62.5%
Total debt$52.8M-4.2%
Total equity$1.2B-8.2%
Total assets$1.9B-12.8%

Cash flow

See full
Operating cash flow-$19.3M+44.1%
CapEx$1.8M-42.6%
Free cash flow-$21.1M+44.0%

Valuation

See full
Market cap$1.13B+10.0%
P/S1.9×+0.5×

Profitability

See full
Gross margin36%+4.2pp
Operating margin-17.4%-5.6pp
Net margin-36.6%-44.8pp
FCF margin-30%+0.1pp

Returns & leverage

See full
Return on equity-16.9%-21.7pp
Debt / equity0.0×
Current ratio3.6×+1.1×

Where this comes from

Calculated from Opko Health’s reported figures.

Based on trailing twelve months.

The official record: Opko Health’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Opko Health's ebitda margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Opko Health's EBITDA margin?
Opko Health (OPK) reported EBITDA margin of -1.9% in Q1 2026.
How has Opko Health's EBITDA margin changed year-over-year?
Opko Health's EBITDA margin increased by 90.3% year-over-year, from -19.3% to -1.9%.
What is the long-term trend for Opko Health's EBITDA margin?
Over 4 years (2020 to 2025), Opko Health's EBITDA margin has grown at a -19.2% compound annual growth rate (CAGR), from 10% to -4.2%.
What does EBITDA margin mean?
EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.